Publications by authors named "Olaf Neumann"

Claim this Profile
D
Differentiating Main-Duct IPMN from Chronic Pancreatitis Using Next-Generation Sequencing of Main Pancreatic Duct Fluid: A Pilot Study.
Daniel Schmitz, Stefan Prax, Martin Kliment, Felix Gocke, Daniel Kazdal, Olaf Neumann

Diagnostics (Basel)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic landscape and molecularly informed therapy in thymic carcinoma and other advanced thymic epithelial tumors.
Lino Möhrmann, Lysann Rostock, Maximilian Werner, Małgorzata Oleś, Jonas S Arnold, Olaf Neumann

Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "A reproducibility study on invasion in small pulmonary adenocarcinoma according to the WHO and a modified classification, supported by biomarkers" [Lung Cancer 199 (2025) 108060].
Erik Thunnissen, Hans Blaauwgeers, Federica Filipello, Birgit Lissenberg-Witte, Yuko Minami, Olaf Neumann

Lung Cancer· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spatial single-cell profiling and neighbourhood analysis reveal the determinants of immune architecture connected to checkpoint inhibitor therapy outcome in hepatocellular carcinoma.
Henrike Salié, Lara Wischer, Antonio D'Alessio, Ira Godbole, Yuan Suo, Olaf Neumann

Gut· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Implementation of a High-Throughput Automated Comprehensive Genomic Profiling Test: TruSight Oncology 500 HT.
Markus Ball, Eva Romanovsky, Fabian Schnecko, Martina Kirchner, Olaf Neumann

J Mol Diagn· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A reproducibility study on invasion in small pulmonary adenocarcinoma according to the WHO and a modified classification, supported by biomarkers.
Erik Thunnissen, Hans Blaauwgeers, Federica Filipello, Birgit Lissenberg-Witte, Yuko Minami, Olaf Neumann

Lung Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benchmarking whole exome sequencing in the German network for personalized medicine.
Michael Menzel, Mihaela Martis-Thiele, Hannah Goldschmid, Alexander Ott, Eva Romanovsky, Olaf Neumann

Eur J Cancer· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KRAS and TP53 co-mutation predicts benefit of immune checkpoint blockade in lung adenocarcinoma.
Jan Budczies, Eva Romanovsky, Martina Kirchner, Olaf Neumann, Miriam Blasi

Br J Cancer· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep Learning-Enabled Diagnosis of Liver Adenocarcinoma.
Thomas Albrecht, Annik Rossberg, Jana Dorothea Albrecht, Jan Peter Nicolay, Beate Katharina Straub, Olaf Neumann

Gastroenterology· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of rare fusions in NSCLC: Genomic architecture and clinical implications.
Huriye Seker-Cin, Timothy Kwang Yong Tay, Daniel Kazdal, Klaus Kluck, Markus Ball, Olaf Neumann

Lung Cancer· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicentric pilot study to standardize clinical whole exome sequencing (WES) for cancer patients.
Michael Menzel, Stephan Ossowski, Sebastian Kral, Patrick Metzger, Peter Horak, Olaf Neumann

NPJ Precis Oncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NCT/DKFZ MASTER handbook of interpreting whole-genome, transcriptome, and methylome data for precision oncology.
Andreas Mock, Maria-Veronica Teleanu, Simon Kreutzfeldt, Christoph E Heilig, Jennifer Hüllein, Olaf Neumann

NPJ Precis Oncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accurate tumor purity determination is critical for the analysis of homologous recombination deficiency (HRD).
Michael Menzel, Volker Endris, Constantin Schwab, Klaus Kluck, Olaf Neumann

Transl Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First proficiency testing for NGS-based and combined NGS- and FISH-based detection of FGFR2 fusions in intrahepatic cholangiocarcinoma.
Olaf Neumann, Ulrich Lehmann, Stephan Bartels, Nicole Pfarr, Thomas Albrecht

J Pathol Clin Res· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Profound tumor response to combined CTLA-4 and PD-1 inhibition in systemic fourth line therapy observed in a patient with hepatocellular carcinoma harboring SETD2 and LRP1B mutations.
Florian P Reiter, Monika Rau, Volker Kunzmann, Ralph Kickuth, Ingo Klein, Olaf Neumann

Z Gastroenterol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic architecture of FGFR2 fusions in cholangiocarcinoma and its implication for molecular testing.
Olaf Neumann, Timothy C Burn, Michael Allgäuer, Markus Ball, Martina Kirchner

Br J Cancer· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of copy number alterations and tumor mutational burden in carcinoma of unknown primary.
Tilmann Bochtler, Timothy Wohlfromm, Thomas Hielscher, Damian Stichel, Maria Pouyiourou, Olaf Neumann

Genes Chromosomes Cancer· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Genes and pathways: FGFR2 translocations and gene fusion analysis].
Olaf Neumann, Markus Ball, Ulrich Lehmann, Peter Schirmacher, Albrecht Stenzinger

Pathologie (Heidelb)· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Erratum to: Genes and pathways: FGFR2 translocations and gene fusion analysis].
Olaf Neumann, Markus Ball, Ulrich Lehmann, Peter Schirmacher, Albrecht Stenzinger

Pathologie (Heidelb)· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assigning evidence to actionability: An introduction to variant interpretation in precision cancer medicine.
Peter Horak, Jonas Leichsenring, Hannah Goldschmid, Simon Kreutzfeldt, Daniel Kazdal, Olaf Neumann

Genes Chromosomes Cancer· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers.
Peter Horak, Christoph Heining, Simon Kreutzfeldt, Barbara Hutter, Andreas Mock, Olaf Neumann

Cancer Discov· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Local ablative treatment with surgery and/or radiotherapy in single-site and oligometastatic carcinoma of unknown primary.
Maria Pouyiourou, Timothy Wohlfromm, Bianca Kraft, Thomas Hielscher, Damian Stichel, Olaf Neumann

Eur J Cancer· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Peter Horak, Jonas Leichsenring, Simon Kreutzfeldt, Daniel Kazdal, Veronica Teleanu, Olaf Neumann

Pathologe· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KRAS/GNAS-testing by highly sensitive deep targeted next generation sequencing improves the endoscopic ultrasound-guided workup of suspected mucinous neoplasms of the pancreas.
Daniel Schmitz, Daniel Kazdal, Michael Allgäuer, Marcus Trunk, Sylke Vornhusen, Olaf Neumann

Genes Chromosomes Cancer· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Variant interpretation in molecular pathology and oncology : An introduction].
Peter Horak, Jonas Leichsenring, Simon Kreutzfeldt, Daniel Kazdal, Veronica Teleanu, Olaf Neumann

Pathologe· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis